K243872

Substantially Equivalent

BD Veritor System for SARS-CoV-2

Applicant: Becton, Dickinson and Company
Product code: QVF
Advisory panel: Microbiology
Date received: 2024-12-17
Decision date: 2025-06-16
Decision: Substantially Equivalent
Clearance type: Dual Track
Location: Sparks, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.